Skip to main content
Premium Trial:

Request an Annual Quote

Epigenomics Launches Study of Cancer Test Adoption Patterns

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Epigenomics this week said that has launched a study of its Epi proColon test to examine adoption patterns in the market.

The German molecular diagnostics firm launched the colorectal cancer test in Europe in 2009. It is currently being marketed by Epigenomics to privately insured individuals and self-payors in Germany, Austria, and Switzerland and through distributors in other markets, the firm said.

Epigenomics said that it expects the study to include around 300 primary care physicians and up to 3,000 patients getting the Epi proColon test in Germany and Switzerland.

"We expect the results of this study to help with both fine-tuning the positioning of the test in the self-payor market segment and in seeking general reimbursement under the public health care scheme," Juergen Beck, SVP of medical affairs for Epigenomics, said in a statement.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.